Development of a Miniaturized Mechanoacoustic Sensor for Continuous, Objective Cough Detection, Characterization and Physiologic Monitoring in Children With Cystic Fibrosis
- PMID: 38885105
- PMCID: PMC11653413
- DOI: 10.1109/JBHI.2024.3415479
Development of a Miniaturized Mechanoacoustic Sensor for Continuous, Objective Cough Detection, Characterization and Physiologic Monitoring in Children With Cystic Fibrosis
Abstract
Cough is an important symptom in children with acute and chronic respiratory disease. Daily cough is common in Cystic Fibrosis (CF) and increased cough is a symptom of pulmonary exacerbation. To date, cough assessment is primarily subjective in clinical practice and research. Attempts to develop objective, automatic cough counting tools have faced reliability issues in noisy environments and practical barriers limiting long-term use. This single-center pilot study evaluated usability, acceptability and performance of a mechanoacoustic sensor (MAS), previously used for cough classification in adults, in 36 children with CF over brief and multi-day periods in four cohorts. Children whose health was at baseline and who had symptoms of pulmonary exacerbation were included. We trained, validated, and deployed custom deep learning algorithms for accurate cough detection and classification from other vocalization or artifacts with an overall area under the receiver-operator characteristic curve (AUROC) of 0.96 and average precision (AP) of 0.93. Child and parent feedback led to a redesign of the MAS towards a smaller, more discreet device acceptable for daily use in children. Additional improvements optimized power efficiency and data management. The MAS's ability to objectively measure cough and other physiologic signals across clinic, hospital, and home settings is demonstrated, particularly aided by an AUROC of 0.97 and AP of 0.96 for motion artifact rejection. Examples of cough frequency and physiologic parameter correlations with participant-reported outcomes and clinical measurements for individual patients are presented. The MAS is a promising tool in objective longitudinal evaluation of cough in children with CF.
Figures









Similar articles
-
Objective monitoring of cough in children with cystic fibrosis.Pediatr Pulmonol. 2002 Nov;34(5):331-5. doi: 10.1002/ppul.10174. Pediatr Pulmonol. 2002. PMID: 12357476
-
Pulmonary exacerbations in cystic fibrosis: young children with characteristic signs and symptoms.Pediatr Pulmonol. 2013 Jul;48(7):649-57. doi: 10.1002/ppul.22658. Epub 2012 Sep 4. Pediatr Pulmonol. 2013. PMID: 22949088 Free PMC article.
-
Rationale and design of a randomized trial of home electronic symptom and lung function monitoring to detect cystic fibrosis pulmonary exacerbations: the early intervention in cystic fibrosis exacerbation (eICE) trial.Contemp Clin Trials. 2013 Nov;36(2):460-9. doi: 10.1016/j.cct.2013.09.004. Epub 2013 Sep 19. Contemp Clin Trials. 2013. PMID: 24055998 Free PMC article. Clinical Trial.
-
Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis.Cochrane Database Syst Rev. 2019 Jan 7;1(1):CD009841. doi: 10.1002/14651858.CD009841.pub3. Cochrane Database Syst Rev. 2019. PMID: 30616300 Free PMC article.
-
Inhaled mannitol for cystic fibrosis.Cochrane Database Syst Rev. 2020 May 1;5(5):CD008649. doi: 10.1002/14651858.CD008649.pub4. Cochrane Database Syst Rev. 2020. PMID: 32358807 Free PMC article.
Cited by
-
Multimodal deep ensemble classification system with wearable vibration sensor for detecting throat-related events.NPJ Digit Med. 2025 Jan 7;8(1):14. doi: 10.1038/s41746-024-01417-w. NPJ Digit Med. 2025. PMID: 39775108 Free PMC article.
-
Asthma Symptom Self-Monitoring Methods for Children and Adolescents: Present and Future.Children (Basel). 2025 Jul 29;12(8):997. doi: 10.3390/children12080997. Children (Basel). 2025. PMID: 40868448 Free PMC article. Review.